GT200400136A - 3.5-DISPOSED INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT CELLULAR APPROVALIFERATION. - Google Patents

3.5-DISPOSED INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT CELLULAR APPROVALIFERATION.

Info

Publication number
GT200400136A
GT200400136A GT200400136A GT200400136A GT200400136A GT 200400136 A GT200400136 A GT 200400136A GT 200400136 A GT200400136 A GT 200400136A GT 200400136 A GT200400136 A GT 200400136A GT 200400136 A GT200400136 A GT 200400136A
Authority
GT
Guatemala
Prior art keywords
compounds
intervene
disposed
methods
pharmaceutical compositions
Prior art date
Application number
GT200400136A
Other languages
Spanish (es)
Inventor
Susan Elizabeth Kephart
Indrawan James Mcalpine
Seigfried Heins Reich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200400136A publication Critical patent/GT200400136A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE DESCRIBEN COMPUESTOS DE INDAZOL 3,5DISUSTITUIDOS QUE MODULAN Y/O INHIBEN LA PROLIFERACION CELULAR TAL COMO LA ACTIVIDAD DE LAS PROTEINAS QUINASAS. ESTOS COMPUESTOS Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN SON CAPACES DE INTERVENIR EN ENFERMEDADES DEPENDIENTES DE LA CDK PARA MODULAR Y/O INHIBIR LA PROLIFERACION CELULARA NO DESEADA. LA INVENCION TAMBIEN SE DIRIGE AL USO TERAPEUTICO O PROFILACTICO DE COMPOSICIONES FARMACEUTICAS QUE CONTIENEN TALES COMPUESTOS Y A METODOS PARA TRATAR EL CANCER ASI COMO OTRAS CONDICIONES PATOLOGICAS ASOCIADAS CON ANGIOGENESIS Y/O PROLIFERACION CELULAR, NO DESEADA, TALES COMO: RETINOPATIA DIABETICA, GLAUCOMA NEOVASCULAR, ARTRITIS REUMATOIDE Y SORIASIS, POR ADMINISTRACION DE CANTIDADES EFICACES DE TALES COMPUESTOS.INDAZOL COMPOUNDS 3.5 DISPOSED THAT MODULATE AND / OR INHIBIT CELLULAR PROLIFERATION SUCH AS THE ACTIVITY OF KINASE PROTEINS. THESE PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS CONTAINING THEM ARE ABLE TO INTERVENE IN DEPENDENT DISEASES OF THE CDK TO MODULATE AND / OR INHIBIT THE UNWANTED CELLULAR PROLIFERATION. THE INVENTION IS ALSO ADDRESSED TO THE THERAPEUTIC OR PROFILACTIC USE OF PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS TO TREAT CANCER AS WELL AS OTHER PATHOLOGICAL CONDITIONS ASSOCIATED WITH ANGIOGENESIS AND / OR PROLIFTIATIMED ROLLAR, DISTRIBUTED CELEBRATION, ASSOCIATED BY NUMBER REUMATOID AND SORIASIS, BY ADMINISTRATION OF EFFECTIVE AMOUNTS OF SUCH COMPOUNDS.

GT200400136A 2003-07-30 2004-07-19 3.5-DISPOSED INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT CELLULAR APPROVALIFERATION. GT200400136A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49147403P 2003-07-30 2003-07-30

Publications (1)

Publication Number Publication Date
GT200400136A true GT200400136A (en) 2005-05-02

Family

ID=36947517

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200400136A GT200400136A (en) 2003-07-30 2004-07-19 3.5-DISPOSED INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT CELLULAR APPROVALIFERATION.

Country Status (3)

Country Link
CN (1) CN1829713A (en)
GT (1) GT200400136A (en)
ZA (1) ZA200600821B (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2011003239A (en) * 2008-09-26 2011-04-28 Merck Sharp & Dohme Novel cyclic benzimidazole derivatives useful anti-diabetic agents.
US8252812B2 (en) 2009-08-10 2012-08-28 Samumed, Llc Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof
CA2770320A1 (en) * 2009-08-10 2011-02-17 Epitherix, Llc Indazoles as wnt/b-catenin signaling pathway inhibitors and therapeutic uses thereof
JP5822844B2 (en) 2009-12-21 2015-11-24 サミュメッド リミテッド ライアビリティ カンパニー 1H-pyrazolo [3,4-b] pyridine and therapeutic use thereof
CN102675286B (en) * 2011-03-07 2015-08-19 中国科学院上海药物研究所 One class indazole compounds and preparation method thereof, purposes and pharmaceutical composition
EP3473099A1 (en) 2011-09-14 2019-04-24 Samumed, LLC Indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors
PH12017500997A1 (en) 2012-04-04 2018-02-19 Samumed Llc Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
AU2013256141B2 (en) 2012-05-04 2016-05-12 Samumed, Llc 1H-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
CA2897400A1 (en) 2013-01-08 2014-07-17 Samumed, Llc 3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof
WO2016040180A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
WO2016040184A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
WO2016040190A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
WO2016040185A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
WO2016040193A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
WO2016040181A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
WO2016040182A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof
WO2016040188A1 (en) 2014-09-08 2016-03-17 Samumed, Llc 3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
US10285982B2 (en) 2015-08-03 2019-05-14 Samumed, Llc 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
WO2017023996A1 (en) 2015-08-03 2017-02-09 Samumed, Llc. 3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
WO2017024021A1 (en) 2015-08-03 2017-02-09 Samumed, Llc 3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
WO2017024025A1 (en) 2015-08-03 2017-02-09 Sunil Kumar Kc 3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
WO2017023984A1 (en) 2015-08-03 2017-02-09 Samumed, Llc. 3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
US10231956B2 (en) 2015-08-03 2019-03-19 Samumed, Llc 3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
WO2017023989A1 (en) 2015-08-03 2017-02-09 Samumed, Llc. 3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
US10226448B2 (en) 2015-08-03 2019-03-12 Samumed, Llc 3-(1H-pyrrolo[3,2-C]pyridin-2-yl)-1H-pyrazolo[3,4-B]pyridines and therapeutic uses thereof
WO2017023986A1 (en) 2015-08-03 2017-02-09 Samumed, Llc 3-(1h-indol-2-yl)-1h-indazoles and therapeutic uses thereof
WO2017023975A1 (en) 2015-08-03 2017-02-09 Samumed, Llc. 3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
US10329309B2 (en) 2015-08-03 2019-06-25 Samumed, Llc 3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
US10206909B2 (en) 2015-08-03 2019-02-19 Samumed, Llc 3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
US10188634B2 (en) 2015-08-03 2019-01-29 Samumed, Llc 3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
US10195185B2 (en) 2015-08-03 2019-02-05 Samumed, Llc 3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
US10166218B2 (en) 2015-08-03 2019-01-01 Samumed, Llc 3-(1H-indol-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
WO2017023993A1 (en) 2015-08-03 2017-02-09 Samumed, Llc. 3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
WO2017024010A1 (en) 2015-08-03 2017-02-09 Samumed, Llc. 3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
CA3004506A1 (en) 2015-11-06 2017-05-11 Samumed, Llc Use of n-(5-(3-(7-(3- fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide in the treatment of osteoarthritis
CA3026076A1 (en) 2016-06-01 2017-12-07 Samumed, Llc Process for preparing n-(5-(3-(7-(3-fluorophenyl)-3h-imidazo[4,5-c]pyridin-2-yl)-1h-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide
WO2018075858A1 (en) 2016-10-21 2018-04-26 Samumed, Llc Methods of using indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors
JP2019533702A (en) 2016-11-07 2019-11-21 サミュメッド リミテッド ライアビリティ カンパニー Single dose adjusted injectable formulation

Also Published As

Publication number Publication date
ZA200600821B (en) 2007-04-25
CN1829713A (en) 2006-09-06

Similar Documents

Publication Publication Date Title
GT200400136A (en) 3.5-DISPOSED INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT CELLULAR APPROVALIFERATION.
PA8608201A1 (en) INDAZOL COMPOUNDS 3,5-DISPOSED, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT THE CELL PROLIFERATION
DOP2001000120A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS OF INDAZOL AND METHODS TO MEASURE AND INHIBIT THE CELL PROLIFERATION
GT200100014A (en) AMIDA COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINASES, AND THEIR INSTRUCTIONS FOR USE.
AR023574A1 (en) TETRACICLIC AZEPININDOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH COMPOUNDS TO PREPARE A MEDICINAL PRODUCT, AND INTERMEDIARIES
SV2002000121A (en) INDAZOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT THE PROTEIN KINASES AND METHOD FOR USE
UY26190A1 (en) TIAZOLE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR INHIBITING PROTEINKINASES AND METHODS FOR THEIR USE
GT200100061A (en) PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS AND METHODS TO INHIBIT PROTEIN KINASES.
ES2183937T3 (en) INHIBITORS OF THE CELL ADHESION.
UY28213A1 (en) NEW CYANOPIRIDINE DERIVATIVES USEFUL IN THE TREATMENT OF CANCER AND OTHER DISORDERS.
PA8592901A1 (en) INDAZOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINES, AND PROCEDURES FOR USE
PA8493701A1 (en) COMPOUNDS TO TREAT OBESITY
BR9808010B1 (en) 2-ALKYL-19-NOR-VITAMIN D COMPOUNDS AND PHARMACEUTICAL COMPOSITION UNDERSTANDING THE SAME
HN1999000080A (en) ISOTIAZOL DERIVATIVES USEFUL AS ANTI-CANCER AGENTS.
AR026410A1 (en) '' 2-ARIL-3- (HETEROARIL) -IMIDAZO [1,2-A] SUBSTITUTED PYRIMIDINS, AND RELATED PHARMACEUTICAL COMPOSITIONS AND METHODS
PA8550101A1 (en) DERIVATIVES OF BENZAMIDA TIAZOL AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT THE PROLIFERATION OF CELLS, AND METHODS FOR USE
BR0211559A (en) Therapeutically useful compounds, tetracyclic binder compositions and their uses
UY26877A1 (en) PIRAZOL-TIAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, AND ITS INSTRUCTIONS FOR INHIBITING CYCLINE-DEPENDENT KINASES
MXPA03008635A (en) Cyano-substituted dihydropyrimidine compounds and their use to treat diseases.
UY27232A1 (en) NEW SUBSTITUTED CYAN DIHYDROPIRIMIDINE COMPOUNDS AND THEIR USE FOR TREATMENT OF MATTERS
CL2004000631A1 (en) COMPOUNDS DERIVED FROM ACID 6- (2-BROMOFENIL) -PIRIDO [2,3-DIPIRIMIDIN-7-CARBOXILICO; PHARMACEUTICAL COMPOSITION; PREPARATION PROCEDURE; AND USE TO TREAT CANCER AND TO PREPARE MEDICATIONS TO INHIBIT TUMOR GROWTH.
PA8525701A1 (en) COMPOUNDS WITH HETEROCICLIC-HYDROXIMINE-FLUORENE NUCLEES AND PHARMACEUTICAL COMPOSITIONS FOR THE INHIBITION OF KINASE PROTEINS AND METHODS FOR USE
DOP2004000953A (en) INDAZOL COMPOUNDS 3,5-DISPOSED, PHARMACEUTICAL COMPOSITIONS AND METHODS TO INTERVENE IN OR INHIBIT THE CELL PROLIFERATION.
CL2004000630A1 (en) COMPOUNDS DERIVED FROM OXAZOL; SALTS OF SUCH COMPOUNDS; PROCEDURE FOR PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION CONTAINING SUCH COMPOUNDS; AND ITS USE TO INHIBIT TUMOR GROWTH.
UY26543A1 (en) INDAZOL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MEASURING OR INHIBITING CELL PROLIFERATION.